Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier-Reference-Cited by-同舟云学术

Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier

Published:1988-01 Issue:23 Volume:42 Page:2359-2363
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Riachi Naji J.,Harik Sami I.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference14 articles.

1. MPTP and parkinson's disease

2. MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease: The 1985 George C. Cotzias Lecture

3. IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects

4. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition;Molecular Neurobiology;2023-01-03

2. Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease;International Journal of Molecular Sciences;2022-04-19

3. Drug Metabolism at the Blood-Brain and Blood-CSF Barriers;Drug Delivery to the Brain;2022

4. Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions;Pharmacological Reviews;2018-03-01

5. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss;NeuroToxicology;2017-05